￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical News

The third-generation targeted drug for lung cancer, lorlatinib, can significantly improve the survival of patients with ALK-positive non-small cell lung cancer_ Kanghule

2025-10-19 11:44:20

Check Details
How much does a box of lung cancer targeted drug lorlatinib cost? Where to buy it?

2025-10-19 11:44:20

Check Details
What should I do if my lung cancer becomes resistant to lorlatinib?

2025-10-19 11:44:20

Check Details
How long can patients with advanced lung cancer live after taking lorlatinib?

2025-10-19 11:44:20

Check Details
The effect of vandetanib in the treatment of lung cancer patients with specific gene mutations

2025-10-19 11:44:20

Check Details
Third-generation ALK inhibitor for lung cancer: lorlatinib

2025-10-19 11:44:20

Check Details
Special lung cancer targeting drug vandetanib

2025-10-19 11:44:20

Check Details
Effects and adverse reactions of lorlatinib in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Precautions when treating lung cancer patients with vandetanib

2025-10-19 11:44:20

Check Details
Which type of lung cancer does vandetanib have a good effect on?

2025-10-19 11:44:20

Check Details
How much does a box of Vandetanib cost after it is included in medical insurance in 2021?

2025-10-19 11:44:20

Check Details
How effective is dacomitinib tablets for lung cancer?

2025-10-19 11:44:20

Check Details
Category
相关知识